Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis.

Subjects

Subjects :

*AMYLOIDOSIS treatment
*ATRIAL natriuretic peptides
*PEPTIDE hormones
*BIOMARKERS
*TROPONIN
*CARDIOLOGY
*MEDICAL research

Details

Language :

English

ISSN :

01675273

Volume :

176

Issue :

3

Database :

Academic Search Index

Journal :

International Journal of Cardiology

Publication Type :

Academic Journal

Accession number :

98792521

Full Text :

https://doi.org/10.1016/j.ijcard.2014.07.106